Precision Meets Progress: Transforming Breast Cancer Care

October marks Breast Cancer Awareness Month, a time dedicated to increasing awareness of the most diagnosed cancer among women in the U.S. and promoting the critical importance of early detection and personalized treatment. At Extract Systems, we are proud to support innovative healthcare organizations like Exact Sciences, a leader in the fight against breast cancer, particularly through their precision oncology solutions.

The Role of Precision Oncology in Breast Cancer Treatment

Breast cancer treatment has evolved significantly over the past decades. As researchers and healthcare providers work to better understand the genetic factors driving individual cases of breast cancer, precision oncology is transforming the approach to diagnosis and treatment. Rather than a one-size-fits-all method, precision oncology tailors treatments to the unique genetic makeup of each patient’s cancer, maximizing the effectiveness of therapy while minimizing unnecessary interventions.

This is where Exact Sciences and their breast cancer precision oncology group are making a significant impact.

Exact Sciences and the Power of the Oncotype DX® Test

One of the cornerstone innovations in breast cancer precision medicine is Exact Sciences’ Oncotype DX® test. This groundbreaking diagnostic test analyzes the activity of 21 genes within a breast cancer tumor to determine the likelihood of recurrence and the potential benefit of chemotherapy for individual patients.

For women diagnosed with early-stage invasive breast cancer or ductal carcinoma in situ (DCIS), the Oncotype DX® test provides invaluable data. This information helps oncologists and patients make informed decisions about treatment paths, particularly whether chemotherapy will be beneficial, ultimately reducing the risk of over-treatment and unnecessary side effects.

Precision Data, Accurate Decisions

At Extract Systems, we understand the importance of precision in both healthcare and the handling of critical data. Our platform aids healthcare organizations like Exact Sciences in ensuring the accurate extraction and management of vital information from unstructured sources, including medical records, pathology reports, and lab results.

By automating the extraction of essential data, our technology supports the kind of informed, precise decision-making that is at the heart of precision oncology. The Oncotype DX® test relies on accurate patient data, and we’re proud to contribute to workflows that ensure this information is available, reliable, and actionable.

Raising Awareness and Supporting Progress

As we recognize Breast Cancer Awareness Month, it is a reminder of the importance of continued advancements in both research and technology. Exact Sciences' Oncotype DX® test is a prime example of how innovation in precision oncology is improving outcomes for breast cancer patients around the world.

Extract is committed to supporting organizations like Exact Sciences as they work to develop tools that change the future of cancer treatment. Together, we can help empower patients with the knowledge they need to make informed decisions about their health and treatment.

This October let’s not only spread awareness of breast cancer but also celebrate the remarkable strides being made in precision oncology and data management that are transforming patient care.

Meet the Author: Taylor Genter

Taylor is a Marketing Manager at Extract specializing in marketing strategy and planning. With a strong background in data analytics, graphic design, and digital and social media marketing, she brings a comprehensive skill set to her role. She earned her Bachelor of Business Administration degree in Marketing at the University of Wisconsin- Whitewater. Taylor enjoys analyzing people’s behaviors and attitudes to find out what motivates them, and then curating better ways to communicate with them.